Nuvalent (NUVL) Total Current Liabilities (2020 - 2026)
Nuvalent (NUVL) posted Total Current Liabilities of $81.1 million for Q1 2026, down 11.1% on a QoQ basis from $91.2 million in Q4 2025, and up 8.02% year-over-year from $75.0 million in Q1 2025.
Nuvalent (NUVL) Total Current Liabilities (2020 - 2026) Analysis & Trends
Nuvalent's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $81.1 million for Q1 2026.
- Quarterly Total Current Liabilities rose 8.02% year-over-year to $81.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.1 million (up 8.02% YoY) and the FY2025 annual result came in at $91.2 million, up 68.77% from the prior year.
- Total Current Liabilities was $81.1 million for Q1 2026 at Nuvalent, down from $91.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $91.2 million in Q4 2025 and bottomed at $8.1 million in Q1 2022.
- A 5-year average of $43.4 million and a median of $33.4 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2025 — Total Current Liabilities surged 124.47% — and 2026, when it advanced 8.02%.
- Nuvalent's Total Current Liabilities stood at $19.5 million in 2022, then jumped by 63.35% to $31.8 million in 2023, then soared by 69.75% to $54.0 million in 2024, then jumped by 68.77% to $91.2 million in 2025, then dropped by 11.1% to $81.1 million in 2026.
- Business Quant data shows NUVL's Total Current Liabilities at $81.1 million in Q1 2026, $91.2 million in Q4 2025, and $89.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 81.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.05 Mn |
| Dec 31, 2025 | 91.17 Mn |
| Sep 30, 2025 | 89.15 Mn |
| Jun 30, 2025 | 75.15 Mn |
| Mar 31, 2025 | 75.03 Mn |
| Dec 31, 2024 | 54.02 Mn |
| Sep 30, 2024 | 51.13 Mn |
| Jun 30, 2024 | 38.19 Mn |
| Mar 31, 2024 | 33.43 Mn |
| Dec 31, 2023 | 31.82 Mn |
| Sep 30, 2023 | 29.10 Mn |
| Jun 30, 2023 | 20.80 Mn |
| Mar 31, 2023 | 17.02 Mn |
| Dec 31, 2022 | 19.48 Mn |
| Sep 30, 2022 | 12.98 Mn |
| Jun 30, 2022 | 10.04 Mn |
| Mar 31, 2022 | 8.12 Mn |
| Dec 31, 2021 | 8.79 Mn |
| Sep 30, 2021 | 6.84 Mn |
| Jun 30, 2021 | 5.83 Mn |